Related Experiment Video
Updated: Aug 1, 2025
15:48
ALS - Motor Neuron Disease: Mechanism and Development of New Therapies
Published on: July 29, 2007
9.7K
SLE is not a one-size-fits-all disease
Michael R Ehrenstein1, Muhammad Shipa1
1Department of Rheumatology, University College London , London, UK.
The Journal of Experimental Medicine
|April 25, 2023
Summary
Experimental medicine in clinical trials can address unmet needs in systemic lupus erythematosus (SLE), a prototypic autoimmune disease. This approach aims to improve patient outcomes by advancing treatment strategies.
Area of Science:
- Autoimmune diseases
- Clinical immunology
- Translational medicine
Background:
- Systemic lupus erythematosus (SLE) is a complex autoimmune disease with significant unmet therapeutic needs.
- Current treatments for SLE have limitations in efficacy and tolerability for many patients.
Purpose of the Study:
- To discuss the application of experimental medicine within clinical trials for SLE.
- To highlight how this approach can address unmet needs and improve patient outcomes.
Main Methods:
- Review of experimental medicine strategies in the context of SLE clinical trials.
- Analysis of how targeted approaches can accelerate therapeutic development.
Main Results:
- Experimental medicine offers a framework to systematically evaluate novel therapeutic targets in SLE.
- Integration of basic science discoveries into clinical trials is crucial for progress.
Conclusions:
- Applying experimental medicine principles in SLE clinical trials is essential for addressing unmet needs.
- This strategy holds promise for improving the management and outcomes for patients with systemic lupus erythematosus.
More Related Videos
09:08Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling
Published on: October 14, 2021
5.6K
10:18From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia
Published on: October 19, 2014
13.8K
Related Concept Videos
01:24Nephrotic Syndrome I : Introduction
11
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
11
02:50Combination Therapies and Personalized Medicine
5.0K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.0K
01:33Pleiotropy
40.7K
Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
40.7K
01:27Disorders of Leukocytes
996
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
996
01:26Nephrotic Syndrome II : Assessment and Medical Management
11
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
11
01:17Other Pulmonary Disorders
878
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
878